SCHEMBL31667552

SCHEMBL31667552

Cc1ccc2c(c1)[C@H](C)N(Cc1ccc3[nH]c(=O)oc3c1)C2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 2/20 0.51
▸ NOS3 P29474 1/20 0.42
▸ NOS2 P35228 1/20 0.42
▸ IL4I1 Q96RQ9 1/20 0.39
▸ ALPL P05186 4/20 0.38
▸ ALPI P09923 3/20 0.38
▸ POLB P06746 3/20 0.38
▸ ALPG P10696 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ CREBBP Q92793 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ DRD2 P14416 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31667528 0.88 IL4I1 (0.39) NOS1IL4I1PDE10ACREBBPKDM4E
SCHEMBL31666978 0.88 GRIN2D (0.41) NOS1IL4I1MAOAMAOBPDE10A
SCHEMBL31667564 0.88 IL4I1 (0.39) NOS1IL4I1MEN1KMT2AMAOA
SCHEMBL31666950 0.88 IL4I1 (0.39) NOS1IL4I1MEN1KMT2AMAOA
SCHEMBL31667541 0.88 IL4I1 (0.39) NOS1IL4I1PDE10ACREBBPKDM4E
SCHEMBL31667589 0.88 NOS1 (0.41) NOS1NOS3NOS2IL4I1POLB
SCHEMBL31667115 0.87 IL4I1 (0.46) NOS1IL4I1POLBMEN1GAA
SCHEMBL31667642 0.87 IL4I1 (0.46) NOS1IL4I1POLBMEN1GAA
SCHEMBL31666976 0.87 IL4I1 (0.46) NOS1IL4I1POLBMEN1GAA
SCHEMBL31667211 0.86 PTGDR (0.44) NOS1IL4I1MAOAMAOBPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed
EP-4590674-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2025-07-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 NOS1 2579/4885NOS3 2690/4885NOS2 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback